|Basis of Allotment|
(This is only an advertisement for Information purposes and not a Prospectus announcement.)
TEJNAKSH HEALTHCARE LIMITED
Our Company was originally Incorporated at Mumbal as "Tejnaksh Healthcare Private Limited" on 18" February, 2008 underthe provisions of the Companies Act, 1956. Our Company was converted In to a Public Limited Company and consequently the name was changed to "Tejnaksh Healthcare Limited" vide fresh certificate of Incorporation dated 10" March, 2015 Issued by the Registrar of Companies, Mumbai, Maharashtra. Forfurther details in relation to the changes to the name of our Company, please refer to the section titled "Our History and Corporate Structure" beginning on page 86 of the Prospectus.
Registered Office: Unit No.11, Ground Floor, Town
Centre, Andherl Kuria Road, Marol, Andheri (East), Mumbal-400 059; Tel:
91 -22- 40051526 Hospital & Corporate Office: Institute of Urology,
Sakri Road, Dhule-424 001, Maharashtra; Tel: 91 -2562- 245995/245322; Fax:
91 -2562-248332 Email: firstname.lastname@example.org;
PROMOTERS OF THE COMPANY: DR. ASHISH VISHWAS RAWANNDALE
BASIS OF ALLOTMENT
PUBLIC ISSUE OF 3,04,000 EQUITY SHARES OF RS. 10/- EACH ("EQUITY SHARES") OF TEJNAKSH HEALTHCARE LIMITED ("THL" OR THE "COMPANY" OR THE "ISSUER") FOR CASH AT A PRICE OF RS. 80/- PER SHARE (THE "ISSUE PRICE"), AGGREGATING TO RS. 243.20 LACS ("THE ISSUE"), OF WHICH, 16,000 EQUITY SHARES OF RS. 10 EACH WILL BE RESERVED FOR SUBSCRIPTION BY MARKET MAKERS TO THE ISSUE (THE "MARKET MAKER RESERVATION PORTION"). THE ISSUE LESS THE MARKET MAKER RESERVATION PORTION I.E. ISSUE OF 2,88,000 EQUITY SHARES OF RS. 10 EACH IS HEREINAFTER REFERRED TO AS THE "NET ISSUE". THE ISSUE AND THE NET ISSUE WILL CONSTITUTE 27.54% AND 26.09%, RESPECTIVELY OF THE POST ISSUE PAID UP EQUITY SHARE CAPITAL OF THE COMPANY.
In terms of Prospectus dated 18" September, 2015 and as per Regulation 43 (4) of SEBI (ICDR) Regulations, 2009 wherein a minimum of 50 % of the Net Offer to Public shall be made available to shall be Initially made available to Retail Individual Investors as the case may be. The balance net offer of shares to the public shall be made available for allotment to a) Individual applicants other than retail investors and b) other investors Including corporate bodies/ institutions irrespective of no. of shares applied for. The unsubscribed portion of the net offerto any one of the categories specified in (a) or (b) shall/may be made available for allocation in any other category, if so required. Explanation: for the purpose of Regulation 43 (4) of SEBI (ICDR) Regulations, 2009, if the retail individual investor is entitled to more than fifty percent, on proportionate basis, the retail individual investors shall be allocated that higher percentage.
THE FACE VALUE OF THE EQUITY SHARES IS RS. 10/- EACH AND THE
ISSUE PRICE IS RS. 80/- EACH.
The Equity Shares offered through the Prospectus are proposed to be listed on the SME platform of BSE Limited ("BSE") in terms of the chapter XB of the SEBI (ICDR) Regulations, 2009 as amended from time to time, Company is not required to obtain an in-principle approval of the shares being offered in this Issue. However Company has received an approval letter dated 1" July, 2015 from BSE for using its name in the offer document for listing of our Shares on the SME platform of BSE. The designated stock exchange is BSE Limited.
All Applicants were allowed to participate in the Issue through APPLICATION SUPPORTED BY BLOCKED AMOUNT ("ASBA") process by providing the details of the respective bank accounts in which the corresponding application amounts were blocked by Self Certified Syndicate Banks (the "SCSBs").
The Issue has received 104 applications for 4,20,800 Equity Shares (Including Market Maker Application of 16,000 Equity Shares) resulting 1.384 times subscription. After considering, cheque return cases of 1 application of 1,600 Equity Shares, the Issue was subscribed 1.379 times. The details of the applications received in the Issue (before technical rejections) are as follows:
Detail of the Applications Received (Before Technical Rejection & withdrawal of application):
The details of applications rejected by the Registrar on technical grounds (including withdrawal) are detailed below:
Detail of the Applications Received (After Technical Rejection & withdrawal):
ALLOCATION: The Basis of Allotment was finalized in consultation with the Designated Stock Exchange - BSE Limited on 20th October, 2015
A. Allocation to Market Maker (After Technical Rejections & Withdrawal): The Basis of Allotment to the Market Maker, at the issue price of Rs. 80/- per Equity Share, was finalised in consultation with BSE. The category was subscribed by 1.000 time. The total number of shares allotted in this category is 16,000 Equity shares in full out of reserved portion of 16,000 Equity Shares.
B. Allocation to Retail Individual Investors (After Technical Rejections & Withdrawal): The Basis of Allotmentto the Retail Individual Investors, atthe issue price of Rs. 80/- per Equity Share, was finalized in consultation with BSE. The category was subscribed by 0.733 times. Total number of shares allotted in this category is 1,05,600 Equity Shares. The balance 38,400 Shares has been added to Non Retail Category as spill over.
The category wise basis of allotment is as under:
C. Allocation to Non Retail Investors (After Technical Rejections & Withdrawal): The Basis of Allotment to the Non Retail Investors, at the issue price of Rs. 80/- per Equity Share, was finalized in consultation with BSE. The category was subscribed by 2.044 times. Total number of shares allotted in this category is 1,82,400 Equity Shares including spill over of 38,400 Shares from Retail Category.
The category wise basis of allotment is as under:
* Includes 38,400 Shares spill over from retail category
The Board of Directors of the Company at its meeting held on 20" October, 2015 has taken on record the Basis of Allocation of Equity Shares approved by the Designated Stock Exchange viz. BSE and has authorized the corporate action forthe transfer of the Equity Shares/dispatch of share certificates to various successful applicants. The CAN-cum-Refund Orders and allotment advice and/or notices are being dispatched to the address of the Applicants as registered with the depositories/ as filled in the application form on or before 23" October, 2015. Further, the instructions to Self Certified Syndicate Banks being processed on or prior to 23" October, 2015. In case the same is not received within 10 days, investors may contact at the address given below. The Equity Shares allocated to successful applicants are being credited to their beneficiary accounts subject to validation of the account details with the depositories concerned. The Company is taking steps to get the Equity Shares admitted for trading on the SME Platform of BSE Limited within Twelve working days from the date of the closure of the Issue. The trading is proposed to be commenced on or before 28" October, 2015 subject to receipt of listing and trading approvals from BSE Limited.
INVESTORS PLEASE NOTE
The details of the allotment made would also be hosted on the website of the Registrar to the Issue, Cameo Corporate Services Limited at www.cameoindia.com All future correspondence in this regard may kindly be addressed to the Registrar to the Issue quoting full name of the First/ Sole applicants, serial number of the Application Form, number of shares applied for and Bank Branch where the application had been lodged and payment details atthe address of the Registrar given below:
CAMEO CORPORATE SERVICES LTD.
THE LEVEL OF SUBSCRIPTION SHOULD NOT BE TAKEN TO BE INDICATIVE OF EITHER THE MARKET
PRICE OF THE EQUITY SHARES ON LISTING OR THE BUSINESS PROSPECTS OF TEJNAKSH